All Updates

All Updates

icon
Filter
Funding
Generate Biomedicines raises USD 370 million Series B
AI Drug Discovery
Nov 18, 2021
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Product updates
Microsoft launches Copilot Actions for workplace automation
Foundation Models
Yesterday
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
AI Drug Discovery

AI Drug Discovery

Nov 18, 2021

Generate Biomedicines raises USD 370 million Series B

Funding

  • Pennsylvania-based AI drug development company Generate Biomedicines has raised USD 370 million in a Series B funding round that included Flagship Pioneering (the company’s founding company), Altitude Life Science Ventures, Arch Venture Partners, and several other institutional investors. This funding marks the company’s first external equity raise.

  • The proceeds will be directed toward further developing the company’s drug generation platform and growing its workforce by more than sixfold (currently employing 80) over the next two years. The funds will also be used to move to two new facilities (Andover and Somerville) to expand Generate’s machine learning, data generation, and wet lab capabilities. 

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.